Aug 19 (Reuters) – Sedana Medical AB (publ): * ANNOUNCES FDA ACCEPTANCE FOR REVIEW OF ITS NEW DRUG APPLICATION IN U.S. Source text: Further company coverage: (Gdansk Newsroom)
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)